Literature DB >> 14061063

WEGENER'S GRANULOMATOSIS; PROLONGED THERAPY WITH LARGE DOSES OF STEROIDS.

B BEIDLEMAN.   

Abstract

Entities:  

Keywords:  CORTISONE; HYDROCORTISONE; PATHOLOGY; PREDNISONE; PREDNISONE TOXICOLOGY; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT; WEGENER'S GRANULOMATOSIS

Mesh:

Substances:

Year:  1963        PMID: 14061063

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Pulmonary vasculitis.

Authors:  A Burns
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

2.  Vasculitides throughout history and their clinical treatment today.

Authors:  Antonio Iglesias-Gamarra; Edgar Penaranda; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

3.  [Wegener's granulomatosis: clinical course and pathologic-anatomical findings during therapy using corticosteroids].

Authors:  U Pfeifer; R Juchems
Journal:  Klin Wochenschr       Date:  1967-08-15

4.  Wegener's granulomatosis exhibiting the clinical features of Goodpasture's syndrome.

Authors:  G Boros; I Orbán; J Nagy
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

5.  Spontaneous pneumothorax in Wegener's granulomatosis.

Authors:  T Jaspan; A M Davison; W C Walker
Journal:  Thorax       Date:  1982-10       Impact factor: 9.139

6.  Acute Wegener's granulomatosis.

Authors:  D Leak; G P Clein
Journal:  Thorax       Date:  1967-09       Impact factor: 9.139

Review 7.  Prostate involvement in granulomatosis with polyangiitis.

Authors:  Roman Yatsyshyn; Olena Zimba; Mykola Bahrii; Bohdana Doskaliuk; Vitalii Huryk
Journal:  Rheumatol Int       Date:  2019-05-09       Impact factor: 2.631

8.  Indolent Wegener's granulomatosis.

Authors:  D G Macfarlane; J T Bourne; P A Dieppe; D L Easty
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 9.  Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives.

Authors:  Philipp Moog; Klaus Thuermel
Journal:  Ther Clin Risk Manag       Date:  2015-11-27       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.